Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

SC Liver Research Consortium

Neither a doctor nor a teaching hospital

Research payments

$143,379

30 payments

Through program year 2025, SC Liver Research Consortium is reported as receiving $143,379 in research payments, across 30 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $97,566 22
2019 Research $45,813 8

Breakdown

Who paid Research payments · program years 2019–2025
  1. Ipsen Pharma SAS $97,566 22 payments
  2. Intercept Pharmaceuticals, Inc. $45,813 8 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Double-blind, Randomized, Placebo-Controlled Study and Open-label Long Term Extension to Evaluate the Efficacy and Safety of Elafibranor 80 mg in Patients With Primary Biliary Cholangitis With Inadequate Response or Intolerance to Ursodeoxycholic Acid $97,566 22 payments
  2. 1012528 $45,813 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record